Show simple item record

A comprehensive review of reported heritable noggin‐associated syndromes and proposed clinical utility of one broadly inclusive diagnostic term: NOG ‐related‐symphalangism spectrum disorder ( NOG ‐SSD)

dc.contributor.authorPotti, Tommy A.en_US
dc.contributor.authorPetty, Elizabeth M.en_US
dc.contributor.authorLesperance, Marci M.en_US
dc.date.accessioned2011-11-10T15:37:51Z
dc.date.available2012-10-01T18:34:38Zen_US
dc.date.issued2011-08en_US
dc.identifier.citationPotti, Tommy A.; Petty, Elizabeth M.; Lesperance, Marci M. (2011). "A comprehensive review of reported heritable noggin‐associated syndromes and proposed clinical utility of one broadly inclusive diagnostic term: NOG ‐related‐symphalangism spectrum disorder ( NOG ‐SSD) ." Human Mutation 32(8): 877-886. <http://hdl.handle.net/2027.42/87082>en_US
dc.identifier.issn1059-7794en_US
dc.identifier.issn1098-1004en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/87082
dc.description.abstractThe NOG gene encodes noggin, a secreted polypeptide that is important for regulating multiple signaling pathways during human development, particularly in cartilage and bone. The hallmark of NOG ‐related syndromes is proximal symphalangism, defined by abnormal fusion of the proximal interphalangeal joints of the hands and feet. Many additional features secondary to NOG mutations are commonly but inconsistently observed, including a characteristic facies with a hemicylindrical nose, congenital conductive hearing loss due to stapes fixation, and hyperopia. The variable clinical presentations led to the designation of five different autosomal dominant syndromes, all subsequently found to have resulted from NOG mutations. These include (1) proximal symphalangism; (2) multiple synostoses syndrome 1; (3) stapes ankylosis with broad thumbs and toes; (4) tarsal‐carpal coalition syndrome; and (5) brachydactyly type B2. Herein, we review the phenotypic features associated with mutations in the NOG gene, demonstrating the overlapping characteristics of these syndromes. Due to the variable phenotypic spectrum within families and among families with the same mutation, we propose a unifying term, NOG ‐related symphalangism spectrum disorder ( NOG ‐SSD), to aid in the clinical recognition and evaluation of all affected individuals with these phenotypes. These NOG gene variants are available in a new locus‐specific database ( https://NOG.lovd.nl ).Hum Mutat 32:1–10, 2011. © 2011 Wiley‐Liss, Inc.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherNogginen_US
dc.subject.otherNOGen_US
dc.subject.otherProximal Symphalangismen_US
dc.subject.otherStapes Ankylosisen_US
dc.titleA comprehensive review of reported heritable noggin‐associated syndromes and proposed clinical utility of one broadly inclusive diagnostic term: NOG ‐related‐symphalangism spectrum disorder ( NOG ‐SSD)en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeneticsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMedical School, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Human Genetics, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDivision of Pediatric Otolaryngology, Department of Otolaryngology–Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDivision of Pediatric Otolaryngology, F6866 Mott 1500 East Medical Center Drive, Ann Arbor, MI 48109‐5241en_US
dc.identifier.pmid21538686en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/87082/1/21515_ftp.pdf
dc.identifier.doi10.1002/humu.21515en_US
dc.identifier.sourceHuman Mutationen_US
dc.identifier.citedreferenceAkarsu A, Rezaie T, Demirtas M, Farhud D, Sarfarazi M. 1999. Multiple synostosis type 2 (SYNS2) maps to 20q11. 2 and caused by a missense mutation in the growth/differentiation factor 5 (GDF5). Am J Hum Genet 65: 1569.en_US
dc.identifier.citedreferenceBaldridge D, Shchelochkov O, Kelley B, Lee B. 2010. Signaling pathways in human skeletal dysplasias. Annu Rev Genomics Hum Genet 11: 189 – 217.en_US
dc.identifier.citedreferenceBaschek V. 1978. [Stapes fixation and proximal symphalangism caused by autosomal dominant transmission] (author's transl). Laryngol Rhinol Otol (Stuttg) 57: 299 – 304.en_US
dc.identifier.citedreferenceBeighton P, Goldberg L, Hof JO. 1978. Dominant inheritance of multiple epiphyseal dysplasia, myopia and deafness. Clin Genet 14: 173 – 177.en_US
dc.identifier.citedreferenceBell J. 1951. Brachydactyly and symphalangism. In: Penrose LS, editor. The treasury of human inheritance. Cambridge: University of Cambridge Press. p 1 – 31.en_US
dc.identifier.citedreferenceBiesecker LG. 1998. Lumping and splitting: molecular biology in the genetics clinic. Clin Genet 53: 3 – 7.en_US
dc.identifier.citedreferenceBloom A. 1937. Hereditary multiple ankylosing arthropathy (congenital stiffness of the finger joints). Radiology 29: 166 – 171.en_US
dc.identifier.citedreferenceBrown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Moroi SE, Gebarski SS, Lesperance MM. 2003. Characterization of a stapes ankylosis family with a NOG mutation. Otol Neurotol 24: 210 – 215.en_US
dc.identifier.citedreferenceBrown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Moroi SE, Milunsky JM, Lesperance MM. 2002. Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 71: 618 – 624.en_US
dc.identifier.citedreferenceBrunet LJ, McMahon JA, McMahon AP, Harland RM. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280: 1455 – 1457.en_US
dc.identifier.citedreferenceCheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. 2003. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85‐A: 1544 – 1552.en_US
dc.identifier.citedreferenceCremers C, Theunissen E, Kuijpers W. 1985. Proximal symphalangia and stapes ankylosis. Arch Otolaryngol 111: 765 – 767.en_US
dc.identifier.citedreferenceCushing H. 1916. Hereditary anchylosis of the proximal phalan‐geal joints (Symphalangism). Genetics 1: 90 – 106.en_US
dc.identifier.citedreferenceda‐Silva EO, Filho SM, de Albuquerque SC. 1984. Multiple synostosis syndrome: study of a large Brazilian kindred. Am J Med Genet 18: 237 – 247.en_US
dc.identifier.citedreferenceDawson K, Seeman P, Sebald E, King L, Edwards M, Williams 3rd J, Mundlos S, Krakow D. 2006. GDF5 is a second locus for multiple‐synostosis syndrome. Am J Hum Genet 78: 708 – 712.en_US
dc.identifier.citedreferenceDebeer P, Fryns JP, Devriendt K, Baten E, Huysmans C, Van de Ven WJ. 2004. A novel NOG mutation Pro37Arg in a family with tarsal and carpal synostoses. Am J Med Genet A 128A: 439 – 440.en_US
dc.identifier.citedreferenceDebeer P, Huysmans C, Van de Ven WJ, Fryns JP, Devriendt K. 2005. Carpal and tarsal synostoses and transverse reduction defects of the toes in two brothers heterozygous for a double de novo NOGGIN mutation. Am J Med Genet A 134: 318 – 320.en_US
dc.identifier.citedreferenceDeclau F, Van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, Van de Heyning P. 2001. Prevalence of otosclerosis in an unselected series of temporal bones. Otol Neurotol 22: 596 – 602.en_US
dc.identifier.citedreferenceden Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15: 7 – 12.en_US
dc.identifier.citedreferencede Kok YJ, van der Maarel SM, Bitner‐Glindzicz M, Huber I, Monaco AP, Malcolm S, Pembrey ME, Ropers HH, Cremers FP. 1995. Association between X‐linked mixed deafness and mutations in the POU domain gene POU3F4. Science 267: 685 – 688.en_US
dc.identifier.citedreferenceDixon ME, Armstrong P, Stevens DB, Bamshad M. 2001. Identical mutations in NOG can cause either tarsal/carpal coalition syndrome or proximal symphalangism. Genet Med 3: 349 – 353.en_US
dc.identifier.citedreferenceDrawbert JP, Stevens DB, Cadle RG, Hall BD. 1985. Tarsal and carpal coalition and symphalangism of the Fuhrmann type. Report of a family. J Bone Joint Surg Am 67: 884 – 889.en_US
dc.identifier.citedreferenceDrinkwater H. 1917. Phalangeal anarthrosis (Synostosis, Ankylosis) transmitted through fourteen generations. Proc R Soc Med 10 ( Pathol Sect ): 60 – 68.en_US
dc.identifier.citedreferenceEmery SB, Meyer A, Miller L, Lesperance MM. 2009. Otosclerosis or congenital stapes ankylosis? The diagnostic role of genetic analysis. Otol Neurotol 30: 1204 – 1208.en_US
dc.identifier.citedreferenceEnsink RJ, Sleeckx JP, Cremers CW. 1999. Proximal symphalangism and congenital conductive hearing loss: otologic aspects. Am J Otol 20: 344 – 349.en_US
dc.identifier.citedreferenceFitch N. 1979. Classification and identification of inherited brachydactylies. J Med Genet 16: 36 – 44.en_US
dc.identifier.citedreferenceGaal SA, Doyle JR, Larsen IJ. 1987. Symphalangism and its introduction into Hawaii: a pedigree. Hawaii Med J 46: 305 – 307.en_US
dc.identifier.citedreferenceGilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P. 2000. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11: 1023 – 1035.en_US
dc.identifier.citedreferenceGong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul‐Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman FR, Reardon W, Patton M, Francomano CA, Warman ML. 1999. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21: 302 – 304.en_US
dc.identifier.citedreferenceGorlin RJ, Kietzer G, Wolfson J. 1970. Stapes fixation a proximal symphalangism. Z Kinderheilkd 108: 12 – 16.en_US
dc.identifier.citedreferenceGregersen HN, Petersen GB. 1977. Congenital malformation of the feet with low body height. A new syndrome, caused by an autosomal dominant gene. Clin Genet 12: 255 – 262.en_US
dc.identifier.citedreferenceGroppe J, Greenwald J, Wiater E, Rodriguez‐Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S. 2002. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420: 636 – 642.en_US
dc.identifier.citedreferenceGroppe J, Greenwald J, Wiater E, Rodriguez‐Leon J, Economides AN, Kwiatkowski W, Baban K, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S. 2003. Structural basis of BMP signaling inhibition by Noggin, a novel twelve‐membered cystine knot protein. J Bone Joint Surg Am 85‐A ( Suppl 3 ): 52 – 58.en_US
dc.identifier.citedreferenceGudbjartsson DF, Walters GB, Thorleifsson G, Stefansson H, Halldorsson BV, Zusmanovich P, Sulem P, Thorlacius S, Gylfason A, Steinberg S, Helgadottir A, Ingason A, Steinthorsdottir V, Olafsdottir EJ, Olafsdottir GH, Jonsson T, Borch‐Johnsen K, Hansen T, Andersen G, Jorgensen T, Pedersen O, Aben KK, Witjes JA, Swinkels DW, den Heijer M, Franke B, Verbeek AL, Becker DM, Yanek LR, Becker LC, Tryggvadottir L, Rafnar T, Gulcher J, Kiemeney LA, Kong A, Thorsteinsdottir U, Stefansson K. 2008. Many sequence variants affecting diversity of adult human height. Nat Genet 40: 609 – 615.en_US
dc.identifier.citedreferenceHerrmann J. 1974. Symphalangism and brachydactyly syndrome: report of the WL symphalangism‐brachydactyly syndrome: review of literature and classification. Birth Defects Orig Artic Ser 10: 23 – 53.en_US
dc.identifier.citedreferenceHigashi K, Inoue S. 1983. Conductive deafness, symphalangism, and facial abnormalities: the WL syndrome in a Japanese family. Am J Med Genet 16: 105 – 109.en_US
dc.identifier.citedreferenceHilhorst‐Hofstee Y, Watkin PM, Hall CM, Baraitser M. 1997. The autosomal dominant syndrome with congenital stapes ankylosis, broad thumbs and hyperopia. Clin Dysmorphol 6: 195 – 203.en_US
dc.identifier.citedreferenceHirshoren N, Gross M, Banin E, Sosna J, Bargal R, Raas‐Rothschild A. 2008. P35S mutation in the NOG gene associated with Teunissen‐Cremers syndrome and features of multiple NOG joint‐fusion syndromes. Eur J Med Genet 51: 351 – 357.en_US
dc.identifier.citedreferenceHogan BL. 1996. Bone morphogenetic proteins in development. Curr Opin Genet Dev 6: 432 – 438.en_US
dc.identifier.citedreferenceHurvitz SA, Goodman RM, Hertz M, Katznelson MB, Sack Y. 1985. The facio‐audio‐symphalangism syndrome: report of a case and review of the literature. Clin Genet 28: 61 – 68.en_US
dc.identifier.citedreferenceHwang CH, Wu DK. 2008. Noggin heterozygous mice: an animal model for congenital conductive hearing loss in humans. Hum Mol Genet 17: 844 – 853.en_US
dc.identifier.citedreferenceKonigsmark BW, Gorlin RJ. 1976. Genetic and metabolic deafness. Philadelphia, PA: W.B. Saunders.en_US
dc.identifier.citedreferenceKosaki K, Sato S, Hasegawa T, Matsuo N, Suzuki T, Ogata T. 2004. Premature ovarian failure in a female with proximal symphalangism and Noggin mutation. Fertil Steril 81: 1137 – 1139.en_US
dc.identifier.citedreferenceKrakow D, Reinker K, Powell B, Cantor R, Priore MA, Garber A, Lachman RS, Rimoin DL, Cohn DH. 1998. Localization of a multiple synostoses‐syndrome disease gene to chromosome 17q21–22. Am J Hum Genet 63: 120 – 124.en_US
dc.identifier.citedreferenceLehmann K, Seemann P, Silan F, Goecke TO, Irgang S, Kjaer KW, Kjaergaard S, Mahoney MJ, Morlot S, Reissner C, Kerr B, Wilkie AO, Mundlos S. 2007. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet 81: 388 – 396.en_US
dc.identifier.citedreferenceMangino M, Flex E, Digilio MC, Giannotti A, Dallapiccola B. 2002. Identification of a novel NOG gene mutation (P35S) in an Italian family with symphalangism. Hum Mutat 19: 308.en_US
dc.identifier.citedreferenceMangold E, Ludwig KU, Birnbaum S, Baluardo C, Ferrian M, Herms S, Reutter H, de Assis NA, Chawa TA, Mattheisen M, Steffens M, Barth S, Kluck N, Paul A, Becker J, Lauster C, Schmidt G, Braumann B, Scheer M, Reich RH, Hemprich A, Pötzsch S, Blaumeiser B, Moebus S, Krawczak M, Schreiber S, Meitinger T, Wichmann HE, Steegers‐Theunissen RP, Kramer FJ, Cichon S, Propping P, Wienker TF, Knapp M, Rubini M, Mossey PA, Hoffmann P, Nöthen MM. 2010. Genome‐wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet 42: 24 – 26.en_US
dc.identifier.citedreferenceMarcelino J, Sciortino CM, Romero MF, Ulatowski LM, Ballock RT, Economides AN, Eimon PM, Harland RM, Warman ML. 2001. Human disease‐causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding. Proc Natl Acad Sci USA 98: 11353 – 11358.en_US
dc.identifier.citedreferenceMaroteaux P, Bouvet JP, Briard ML. 1972. [Multiple synostosis disease]. Nouv Presse Med 1: 3041 – 3047.en_US
dc.identifier.citedreferenceMassey BL, Hillman TA, Shelton C. 2006. Stapedectomy in congenital stapes fixation: are hearing outcomes poorer? Otolaryngol Head Neck Surg 134: 816 – 818.en_US
dc.identifier.citedreferenceMcMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM, McMahon AP. 1998. Noggin‐mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 12: 1438 – 1452.en_US
dc.identifier.citedreferenceMilunsky J, Suntra C, MacDonald CB. 1999. Congenital stapes ankylosis, broad thumbs, and hyperopia: report of a family and refinement of a syndrome. Am J Med Genet 82: 404 – 408.en_US
dc.identifier.citedreferenceMoffett SP, Dillon KA, Yerges LM, Goodrich LJ, Nestlerode C, Bunker CH, Wheeler VW, Patrick AL, Zmuda JM. 2009. Identification and association analysis of single nucleotide polymorphisms in the human noggin (NOG) gene and osteoporosis phenotypes. Bone 44: 999 – 1002.en_US
dc.identifier.citedreferenceNixon JR. 1978. The multiple synostoses syndrome. A plea for simplicity. Clin Orthop Relat Res 48 – 51.en_US
dc.identifier.citedreferenceNohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P. 2002. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP‐2 signaling pathways. J Biol Chem 277: 5330 – 5338.en_US
dc.identifier.citedreferenceOldridge M, Fortuna AM, Maringa M, Propping P, Mansour S, Pollitt C, DeChiara TM, Kimble RB, Valenzuela DM, Yancopoulos GD, Wilkie AO. 2000. Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat Genet 24: 275 – 278.en_US
dc.identifier.citedreferenceOxley CD, Rashid R, Goudie DR, Stranks G, Baty DU, Lam W, Kelnar CJ, Ahmed SF. 2008. Growth and skeletal development in families with NOGGIN gene mutations. Horm Res 69: 221 – 226.en_US
dc.identifier.citedreferencePedersen U. 1984. Hearing loss in patients with osteogenesis imperfecta. A clinical and audiological study of 201 patients. Scand Audiol 13: 67 – 74.en_US
dc.identifier.citedreferencePolymeropoulos MH, Poush J, Rubenstein JR, Francomano CA. 1995. Localization of the gene (SYM1) for proximal symphalangism to human chromosome 17q21–q22. Genomics 27: 225 – 229.en_US
dc.identifier.citedreferenceRudnik‐Schoneborn S, Takahashi T, Busse S, Schmidt T, Senderek J, Eggermann T, Zerres K. 2010. Facioaudiosymphalangism syndrome and growth acceleration associated with a heterozygous NOG mutation. Am J Med Genet A 152A: 1540 – 1544.en_US
dc.identifier.citedreferenceSeemann P, Schwappacher R, Kjaer KW, Krakow D, Lehmann K, Dawson K, Stricker S, Pohl J, Ploger F, Staub E, Nickel J, Sebald W, Knaus P, Mundlos S. 2005. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest 115: 2373 – 2381.en_US
dc.identifier.citedreferenceSherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. 2001. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308 – 311.en_US
dc.identifier.citedreferenceSmith RJ, Lipke RW. 1979. Treatment of congenital deformities of the hand and forearm (second of two parts). N Engl J Med 300: 402 – 407.en_US
dc.identifier.citedreferenceSmith WC, Harland RM. 1992. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70: 829 – 840.en_US
dc.identifier.citedreferenceSpoendlin H. 1974. Congenital stapesankylosis and fusion of tarsal and carpal bones as a dominant hereditary syndrome. Arch Otorhinolaryngol 206: 173 – 179.en_US
dc.identifier.citedreferenceStenger HH, Gloede JF. 1972. [Symphalangisms and stapes ankylosis]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 202: 632 – 634.en_US
dc.identifier.citedreferenceStephan MJ. 2006. A tribute to our teacher, Dr. Judith Hall: a child with the trait of the Earl of Shrewsbury. Am J Med Genet A 140: 156 – 159.en_US
dc.identifier.citedreferenceStrasburger A. 1965. Symphalangism: genetics and clinical aspects. Bull Johns Hopkins Hosp p. 108 – 127.en_US
dc.identifier.citedreferenceSugiura Y, Inagaki Y. 1981. Symphalangism associated with synostosis of carpus and/or tarsus. Jinrui Idengaku Zasshi 26: 31 – 45.en_US
dc.identifier.citedreferenceTakahashi T, Takahashi I, Komatsu M, Sawaishi Y, Higashi K, Nishimura G, Saito H, Takada G. 2001. Mutations of the NOG gene in individuals with proximal symphalangism and multiple synostosis syndrome. Clin Genet 60: 447 – 451.en_US
dc.identifier.citedreferenceTeunissen B, Cremers WR. 1990. An autosomal dominant inherited syndrome with congenital stapes ankylosis. Laryngoscope 100: 380 – 384.en_US
dc.identifier.citedreferenceThomeer HG, Admiraal RJ, Hoefsloot L, Kunst HP, Cremers CW. 2011. Proximal symphalangism, hyperopia, conductive hearing impairment, and the NOG gene: 2 new mutations. Otol Neurotol Feb 25 [Epub ahead of print].en_US
dc.identifier.citedreferenceThometz J. 2000. Tarsal coalition. Foot Ankle Clin 5: 103 – 118, vi.en_US
dc.identifier.citedreferenceValenzuela DM, Economides AN, Rojas E, Lamb TM, Nunez L, Jones P, Lp NY, Espinosa 3rd R, Brannan CI, Gilbert DJ. 1995. Identification of mammalian noggin and its expression in the adult nervous system. J Neurosci 15: 6077 – 6084.en_US
dc.identifier.citedreferencevan den Ende JJ, Mattelaer P, Declau F, Vanhoenacker F, Claes J, Van Hul E, Baten E. 2005. The facio‐audio‐symphalangism syndrome in a four generation family with a nonsense mutation in the NOG‐gene. Clin Dysmorphol 14: 73 – 80.en_US
dc.identifier.citedreferenceVesell ES. 1960. Symphalangism, strabismus and hearing loss in mother and daughter. N Engl J Med 263: 839 – 842.en_US
dc.identifier.citedreferencevon Bubnoff A, Cho KW. 2001. Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol 239: 1 – 14.en_US
dc.identifier.citedreferenceWang X, Xiao F, Yang Q, Liang B, Tang Z, Jiang L, Zhu Q, Chang W, Jiang J, Jiang C, Ren X, Liu JY, Wang QK, Liu M. 2006. A novel mutation in GDF5 causes autosomal dominant symphalangism in two Chinese families. Am J Med Genet A 140A: 1846 – 1853.en_US
dc.identifier.citedreferenceWeekamp HH, Kremer H, Hoefsloot LH, Kuijpers‐Jagtman AM, Cruysberg JR, Cremers CW. 2005. Teunissen‐Cremers syndrome: a clinical, surgical, and genetic report. Otol Neurotol 26: 38 – 51.en_US
dc.identifier.citedreferenceWu XL, Gu MM, Huang L, Liu XS, Zhang HX, Ding XY, Xu JQ, Cui B, Wang L, Lu SY, Chen XY, Zhang HG, Huang W, Yuan WT, Yang JM, Gu Q, Fei J, Chen Z, Yuan ZM, Wang ZG. 2009. Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene. Am J Hum Genet 85: 53 – 63.en_US
dc.identifier.citedreferenceYang W, Cao L, Liu W, Jiang L, Sun M, Zhang D, Wang S, Lo WH, Luo Y, Zhang X. 2008. Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism. J Hum Genet 53: 368 – 374.en_US
dc.identifier.citedreferenceYerges LM, Klei L, Cauley JA, Roeder K, Kammerer CM, Moffett SP, Ensrud KE, Nestlerode CS, Marshall LM, Hoffman AR, Lewis C, Lang TF, Barrett‐Connor E, Ferrell RE, Orwoll ES, Zmuda JM, MrOS Research Group. 2009. High‐density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men. J Bone Miner Res 24: 2039 – 2049.en_US
dc.identifier.citedreferenceZakin L, De Robertis EM. 2010. Extracellular regulation of BMP signaling. Curr Biol 20: R89 – R92.en_US
dc.identifier.citedreferenceZimmerman LB, De Jesus‐Escobar JM, Harland RM. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86: 599 – 606.en_US
dc.identifier.citedreferenceZody MC, Garber M, Adams DJ, Sharpe T, Harrow J, Lupski JR, Nicholson C, Searle SM, Wilming L, Young SK, Abouelleil A, Allen NR, Bi W, Bloom T, Borowsky ML, Bugalter BE, Butler J, Chang JL, Chen CK, Cook A, Corum B, Cuomo CA, de Jong PJ, DeCaprio D, Dewar K, FitzGerald M, Gilbert J, Gibson R, Gnerre S, Goldstein S, Grafham DV, Grocock R, Hafez N, Hagopian DS, Hart E, Norman CH, Humphray S, Jaffe DB, Jones M, Kamal M, Khodiyar VK, LaButti K, Laird G, Lehoczky J, Liu X, Lokyitsang T, Loveland J, Lui A, Macdonald P, Major JE, Matthews L, Mauceli E, McCarroll SA, Mihalev AH, Mudge J, Nguyen C, Nicol R, O'Leary SB, Osoegawa K, Schwartz DC, Shaw‐Smith C, Stankiewicz P, Steward C, Swarbreck D, Venkataraman V, Whittaker CA, Yang X, Zimmer AR, Bradley A, Hubbard T, Birren BW, Rogers J, Lander ES, Nusbaum C. 2006. DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Nature 440: 1045 – 1049.en_US
dc.identifier.citedreferenceZou H, Niswander L. 1996. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272: 738 – 741.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.